Cadegiani Flavio A, Diniz Gustavo C, Alves Gabriella
Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, R. Pedro de Toledo 781, 04039-032 São Paulo, SP Brazil.
Corpometria Institute, an Obesity and Endocrinology Center, SGAS 915 Centro Clínico Advance Salas 260/262/264, 70390-150 Brasilia, DF Brazil.
BMC Obes. 2017 Feb 21;4:9. doi: 10.1186/s40608-017-0147-3. eCollection 2017.
The number of bariatric procedures has exponentially increased in the past decade, as a result of the lack of successful clinical weight-loss interventions. The main reasons for the failure of clinical obesity management are: (1) anti-obesity medications are administered as monotherapies (or pre-combined drugs); (2) lack of combination between pharmacotherapy and non-pharmacological modalities; (3) short duration of pharmacotherapy for obesity; (4) lack of weight-loss maintenance strategies; (5) misunderstanding of the complex pathophysiology of obesity; and (6) underprescription of anti-obesity medications. We developed a protocol that can potentially overcome the drawbacks that may lead to the failure of clinical therapy for obesity. The aim of this study is therefore to report the clinical and metabolic effects of our proposed obesity-management protocol over a 2-year period, and to determine whether this more intensive approach to obesity management is feasible and a possible alternative to bariatric surgery in patients with moderate-to-severe obesity.
This retrospective study involved 43 patients in whom bariatric surgery was indicated. Patients underwent an intensive anti-obesity protocol that included pharmacotherapy with multiple drugs; intense surveillance with monthly body analysis by air-displacement plethysmography, electrical bioimpedance, and 3D body scans; weekly psychotherapy; diet planning with a dietician every 2 months; and exercises at least 3 times a week with exercises prescribed by a personal trainer at least once a month. Body weight (BW), total weight excess (TWE), obesity class, body mass index, fat weight, muscle weight, waist circumference, and visceral fat were analyzed. Markers of lipid and glucose metabolism, liver function, and inflammation were also evaluated. Therapeutic success was defined as >20% BW loss or >50% decrease in TWE after 1 year.
Significant improvements were observed in all clinical and metabolic parameters. Thirty-eight (88.4%) patients achieved 10% BW loss, and 32 (74.4%) achieved 20% BW loss. TWE decreased by >50% in 35 (81.4%) patients. Forty (93.0%) patients were able to avoid bariatric surgery.
An intensive clinical approach to obesity management can be an effective alternative to bariatric surgery, although further randomized controlled studies are necessary to validate our findings.
由于缺乏成功的临床减肥干预措施,在过去十年中,减肥手术的数量呈指数级增长。临床肥胖管理失败的主要原因包括:(1)抗肥胖药物作为单一疗法(或预先组合的药物)使用;(2)药物治疗与非药物治疗方式缺乏结合;(3)肥胖药物治疗持续时间短;(4)缺乏体重维持策略;(5)对肥胖复杂病理生理学的误解;(6)抗肥胖药物处方不足。我们制定了一项方案,该方案有可能克服可能导致临床肥胖治疗失败的缺点。因此,本研究的目的是报告我们提出的肥胖管理方案在两年期间的临床和代谢效果,并确定这种更强化的肥胖管理方法在中重度肥胖患者中是否可行,以及是否可能替代减肥手术。
这项回顾性研究纳入了43例有减肥手术指征的患者。患者接受了强化抗肥胖方案,包括多种药物的药物治疗;通过空气置换体积描记法、生物电阻抗和三维身体扫描进行每月一次身体分析的强化监测;每周一次心理治疗;每两个月与营养师进行一次饮食规划;以及每周至少锻炼3次,由私人教练每月至少规定一次锻炼。分析了体重(BW)、总体重超标(TWE)、肥胖等级、体重指数、脂肪重量、肌肉重量、腰围和内脏脂肪。还评估了脂质和葡萄糖代谢、肝功能和炎症的标志物。治疗成功定义为1年后体重减轻>20%或总体重超标减少>50%。
所有临床和代谢参数均有显著改善。38例(88.4%)患者体重减轻了10%,32例(74.4%)患者体重减轻了20%。35例(81.4%)患者的总体重超标减少>50%。40例(93.0%)患者能够避免减肥手术。
强化的临床肥胖管理方法可以成为减肥手术的有效替代方案,尽管需要进一步的随机对照研究来验证我们的发现。